All In Biotech

Drug Trial Radar · NCT01304485

PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

Phase 2 Study: PET Imaging Characteristics of C11-Acetate in Patients With Prostate Carcinoma, Detection of Recurrent Disease With PSA Relapse

Last checked: Nov 20, 2026Latest source record: Mar 7, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

2,000

Actual

Start

Apr 2011

Primary completion

Jan 2019

Study completion Jan 2019

Sponsor

Lead sponsor
Phoenix Molecular ImagingAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 25, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Positron emission tomography (PET) imaging evaluation in men with recurrent prostate cancer to select patients who may benefit from directed therapy

Conditions

  • Prostate Cancer

Interventions

  • Sodium Acetate C11Drug

    PET Imaging with Sodium Acetate C11

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SUV (Standardized Uptake Value)Time frame: Day1 - Assessed at time of PET imaging - i.e. at the time of primary investigation/PET agent administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Phoenix Molecular Imaging

    Phoenix, Arizona

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.